Home/Filings/4/0001193125-25-264044
4//SEC Filing

Forbes William P 4

Accession 0001193125-25-264044

CIK 0000818033other

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 12:35 PM ET

Size

7.0 KB

Accession

0001193125-25-264044

Insider Transaction Report

Form 4
Period: 2025-10-31
Forbes William P
EVP, Chief Development Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2025-10-3111,694152,027 total
    Exercise: $0.00Common Stock (11,694 underlying)
  • Exercise/Conversion

    Common Stock

    2025-10-31+11,694166,203 total
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).

Documents

1 file

Issuer

HERON THERAPEUTICS, INC. /DE/

CIK 0000818033

Entity typeother

Related Parties

1
  • filerCIK 0001314760

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 12:35 PM ET
Size
7.0 KB